Royalty Reductions. (i) Subject to Section 9.6(c)(iii) below, on a Licensed Product-by-Licensed Product and country-by-country basis, royalties on Net Sales of a Licensed Product in a country shall be reduced by:
Appears in 2 contracts
Samples: Collaboration and License Agreement (Sangamo Therapeutics, Inc), Collaboration and License Agreement (Sangamo Therapeutics, Inc)
Royalty Reductions. (i) Subject to Section 9.6(c)(iii) belowIf, on a country-by-country and Licensed Product-by-Licensed Product and country-by-country basis, royalties [*] such Licensed Product in such country, then the royalty rate on Net Sales of a such Licensed Product in a such country shall be reduced by:[*].
Appears in 1 contract
Royalty Reductions. (i) Subject to Section 9.6(c)(iii) belowThe royalty amounts payable in accordance with Sections 8.6.1 or 8.6.2, as applicable, shall be reduced on a Licensed Product-by-Licensed Product and country-by-country basis, royalties on Net Sales of a Licensed Product in a country shall be reduced bybasis as follows:
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Affimed N.V.)
Royalty Reductions. (i) Subject to Section 9.6(c)(iii) below, on On a Licensed Product-by-Licensed Product and country-by-country and Licensed Product by Licensed Product basis, royalties on Net Sales of a Licensed Product in a country the royalty rates above shall be reduced byduring the royalty term as follows:
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Arcturus Therapeutics Ltd.)
Royalty Reductions. (ia) Subject to Section 9.6(c)(iii) below, on On a Licensed Product-by-Licensed Product and country-by-country basis, royalties on Net Sales of a if such Licensed Product is no longer Covered by a Valid Claim in a such country, then the royalties payable with respect to such Licensed Product pursuant to Section 11.7.1 (Royalty Rates) in such country shall will be reduced by:by [*] during such period.
Appears in 1 contract
Samples: Collaboration and License Agreement (Nurix Therapeutics, Inc.)
Royalty Reductions. (ia) Subject to Section 9.6(c)(iii) below, During the Royalty Term and on a Licensed Product-by-Licensed Product and country-by-country basis, royalties on Net Sales if such Licensed Product is not Covered by a Valid Claim of a Royalty Patent in such country, then the royalties payable with respect to such Licensed Product pursuant to Section 13.10.1 (Royalty Rates) in a such country shall will be reduced by:by [*].
Appears in 1 contract
Samples: Collaboration and License Agreement (Nurix Therapeutics, Inc.)
Royalty Reductions. (i) Subject to Section 9.6(c)(iii) below8.5.3(e), the royalties payable with respect to Annual Net Sales will be reduced, on a Licensed Product-by-Licensed Product and country-by-country basis, to [***] percent ([***]%) of the royalties on Net Sales otherwise payable pursuant to Section 8.5.1, as may be adjusted by Section 8.5.3(b), Section 8.5.3(c) or Section 8.5.3(d), during any portion of a the applicable Royalty Term in which (i) there is not at least one (1) Valid Claim that Covers the sale of such Licensed Product in a such country shall be reduced by:or (ii) [***] in such country.
Appears in 1 contract
